Cwm, LLC Neuronetics, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 54 shares of STIM stock, worth $75. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 54 -0.0%

Holding current value

$75

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Apr 05, 2024	BUY	$2.68 - $4.8 $144 - $259	54 New	54 $0
Q3 2022 Oct 27, 2022	BUY	$2.35 - $4.66 $30,387 - $60,258	12,931 New	12,931 $41,000

Others Institutions Holding STIM

# of Institutions

Shares Held

13.1M

Call Options Held

30.1K

Put Options Held

Kent Lake Pr LLC Anasco, PR

2.08M
Shares

$2.89 Million
0.63% of portfolio
Kent Lake Capital LLC Mill Valley, CA

1.74M
Shares

$2.42 Million
1.44% of portfolio
Cannell Capital LLC Alta, WY

1.31M
Shares

$1.83 Million
0.23% of portfolio
Vanguard Group Inc Valley Forge, PA

1.3M
Shares

$1.81 Million
0.0% of portfolio
Masters Capital Management LLC Atlanta, GA

1.2M
Shares

$1.67 Million
0.05% of portfolio

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account